Institutional Fund
Rosalind Advisors, Inc.
Toronto, OntarioCIK 16226275 filings on record
Portfolio Value
$244.08M
Q1 2026
Holdings
32
Reported positions
New Buys
11
Opened this quarter
QoQ Change
-11.1%
from $274.46M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Delcath Sys Inc12.5%
- Xeris Biopharma Holdings Inc7.7%
- Fennec Pharmaceuticals Inc7.3%
- Savara Inc7.2%
- Vaxcyte Inc6.9%
- Eyepoint Pharmaceuticals Inc5.5%
- Other52.9%
Portfolio Holdings
32 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Delcath Sys Inc | 3.30M | $30.63M | 12.5% | 0 | Held |
| 2 | Xeris Biopharma Holdings Inc | 3.23M | $18.74M | 7.7% | +1.12M | Added |
| 3 | Fennec Pharmaceuticals Inc | 2.91M | $17.89M | 7.3% | +294.7K | Added |
| 4 | Savara Inc | 3.20M | $17.49M | 7.2% | −200.0K | Reduced |
| 5 | Vaxcyte Inc | 290.0K | $16.85M | 6.9% | +290.0K | New |
| 6 | Eyepoint Pharmaceuticals Inc | 1.04M | $13.36M | 5.5% | +346.7K | Added |
| 7 | X4 Pharmaceuticals Inc | 3.21M | $13.28M | 5.4% | +608.8K | Added |
| 8 | Vor Biopharma Inc | 700.0K | $12.49M | 5.1% | +700.0K | New |
| 9 | Mediwound Ltd | 749.1K | $12.07M | 4.9% | 0 | Held |
| 10 | Verastem Inc | 2.14M | $11.33M | 4.6% | +350.0K | Added |
22 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio